Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2008 1
2011 1
2012 1
2015 1
2016 1
2017 1
2019 1
2020 1
2021 1
2022 2
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer.
Swain SM, Baselga J, Kim SB, Ro J, Semiglazov V, Campone M, Ciruelos E, Ferrero JM, Schneeweiss A, Heeson S, Clark E, Ross G, Benyunes MC, Cortés J; CLEOPATRA Study Group. Swain SM, et al. N Engl J Med. 2015 Feb 19;372(8):724-34. doi: 10.1056/NEJMoa1413513. N Engl J Med. 2015. PMID: 25693012 Free PMC article. Clinical Trial.
Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer.
Baselga J, Cortés J, Kim SB, Im SA, Hegg R, Im YH, Roman L, Pedrini JL, Pienkowski T, Knott A, Clark E, Benyunes MC, Ross G, Swain SM; CLEOPATRA Study Group. Baselga J, et al. N Engl J Med. 2012 Jan 12;366(2):109-19. doi: 10.1056/NEJMoa1113216. Epub 2011 Dec 7. N Engl J Med. 2012. PMID: 22149875 Free PMC article. Clinical Trial.
Immunotherapy and Biomarkers in Sarcoma.
Dajsakdipon T, Siripoon T, Ngamphaiboon N, Ativitavas T, Dejthevaporn T. Dajsakdipon T, et al. Among authors: dejthevaporn t. Curr Treat Options Oncol. 2022 Mar;23(3):415-438. doi: 10.1007/s11864-022-00944-6. Epub 2022 Mar 9. Curr Treat Options Oncol. 2022. PMID: 35262852 Review.
Optimizing outcomes for patients with metastatic prostate cancer: insights from South East Asia Expert Panel.
Schutz FAB, Sirachainan E, Kuppusamy S, Hoa NTT, Dejthevaporn T, Bahadzor B, Toan VQ, Chansriwong P, Alip A, Hue NTM, Parinyanitikul N, Tan AL, Hoang VDK, Tienchaiananda P, Chinchapattanam SND, Garg A. Schutz FAB, et al. Among authors: dejthevaporn t. Ther Adv Med Oncol. 2021 Feb 23;13:1758835920985464. doi: 10.1177/1758835920985464. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 33747148 Free PMC article. Review.
Molecular alterations and clinical prognostic factors in resectable non-small cell lung cancer.
Thamrongjirapat T, Muntham D, Incharoen P, Trachu N, Sae-Lim P, Sarachai N, Khiewngam K, Monnamo N, Kantathut N, Ngodngamthaweesuk M, Ativitavas T, Chansriwong P, Nitiwarangkul C, Ruangkanchanasetr R, Kositwattanarerk A, Sirachainan E, Dejthevaporn T, Reungwetwattana T. Thamrongjirapat T, et al. Among authors: dejthevaporn t. BMC Cancer. 2024 Feb 13;24(1):200. doi: 10.1186/s12885-024-11934-2. BMC Cancer. 2024. PMID: 38347487 Free PMC article.
Healthcare coverage affects survival of EGFR-mutant Thai lung cancer patients.
Khiewngam K, Oranratnachai S, Kamprerasart K, Kunakorntham P, Sanvarinda P, Trachu N, Pimsa P, Wiwitkeyoonwong J, Thamrongjirapat T, Dejthevaporn T, Sirachainan E, Reungwetwattana T. Khiewngam K, et al. Among authors: dejthevaporn t. Front Oncol. 2023 Feb 21;13:1047644. doi: 10.3389/fonc.2023.1047644. eCollection 2023. Front Oncol. 2023. PMID: 36895484 Free PMC article.
Giredestrant for Estrogen Receptor-Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study.
Martín M, Lim E, Chavez-MacGregor M, Bardia A, Wu J, Zhang Q, Nowecki Z, Cruz FM, Safin R, Kim SB, Schem C, Montero AJ, Khan S, Bandyopadhyay R, Moore HM, Shivhare M, Patre M, Martinalbo J, Roncoroni L, Pérez-Moreno PD, Sohn J; acelERA Breast Cancer Study Investigators. Martín M, et al. J Clin Oncol. 2024 Mar 27:JCO2301500. doi: 10.1200/JCO.23.01500. Online ahead of print. J Clin Oncol. 2024. PMID: 38537155
17 results